Amexdrug Corporation
AXRX
$0.0021
$0.00015.00%
| 06/30/2013 | 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | |
|---|---|---|---|---|---|
| Revenue | 2.15M | 2.36M | 2.48M | 2.17M | 2.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.15M | 2.36M | 2.48M | 2.17M | 2.31M |
| Cost of Revenue | 1.80M | 1.84M | 2.33M | 1.93M | 2.06M |
| Gross Profit | 356.80K | 518.70K | 150.50K | 235.10K | 255.90K |
| SG&A Expenses | 232.00K | 243.20K | 226.10K | 179.10K | 192.90K |
| Depreciation & Amortization | 17.70K | 17.70K | 12.10K | 2.50K | 2.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.05M | 2.10M | 2.57M | 2.12M | 2.25M |
| Operating Income | 107.10K | 257.90K | -87.60K | 53.60K | 60.50K |
| Income Before Tax | 95.10K | 250.10K | -104.60K | 45.40K | 53.40K |
| Income Tax Expenses | 37.20K | 77.70K | -4.30K | 9.60K | 11.00K |
| Earnings from Continuing Operations | 57.90K | 172.30K | -100.20K | 35.90K | 42.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.90K | 172.30K | -100.20K | 35.90K | 42.30K |
| EBIT | 107.10K | 257.90K | -87.60K | 53.60K | 60.50K |
| EBITDA | 124.80K | 275.50K | -75.50K | 56.00K | 63.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 169.41M | 169.41M | 169.41M | 169.41M | 169.41M |
| Average Diluted Shares Outstanding | 169.41M | 169.41M | 169.41M | 169.41M | 169.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
